|
XRCC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.515700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.020180E-01 |
| Normal-vs-Stage2 |
3.673600E-02 |
| Normal-vs-Stage3 |
2.102200E-02 |
| Normal-vs-Stage4 |
1.664220E-02 |
| Stage1-vs-Stage2 |
2.076800E-01 |
| Stage1-vs-Stage3 |
2.060200E-01 |
| Stage1-vs-Stage4 |
1.850820E-01 |
| Stage2-vs-Stage3 |
7.451600E-01 |
| Stage2-vs-Stage4 |
8.507400E-01 |
| Stage3-vs-Stage4 |
8.934400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.085800E-02 |
| Normal-vs-AfricanAmerican |
8.599800E-01 |
| Normal-vs-Asian |
9.485500E-02 |
| Caucasian-vs-AfricanAmerican |
3.056600E-01 |
| Caucasian-vs-Asian |
8.101000E-01 |
| AfricanAmerican-vs-Asian |
2.925000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.449600E-02 |
| Normal-vs-Female |
4.202300E-02 |
| Male-vs-Female |
4.922800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.543400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.961810E-02 |
| Normal-vs-Age(61-80Yrs) |
1.650030E-02 |
| Normal-vs-Age(81-100Yrs) |
2.687200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.282500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.368200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.470000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.468600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.466000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.533600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.697800E-01 |
| Classical-VS-Follicular |
2.04649999946405E-07 |
| Classical-VS-Other |
2.625000E-01 |
| Classical-VS-Normal |
4.402800E-01 |
| Tall-VS-Follicular |
1.343770E-02 |
| Tall-VS-Other |
4.272200E-01 |
| Tall-VS-Normal |
3.586800E-01 |
| Follicular-VS-Other |
5.792600E-01 |
| Follicular-VS-Normal |
4.01540000000145E-05 |
| Other-VS-Normal |
1.374420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.403100E-03 |
| Normal-vs-N1 |
5.842100E-03 |
| N0-vs-N1 |
5.203800E-01 |
|
|
